{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:51:08Z","timestamp":1762249868133,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.thromres.2025.109452","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:07:53Z","timestamp":1757095673000},"page":"109452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Warfarin reduces circulating white blood cell count: Post-hoc analysis of two randomized trials"],"prefix":"10.1016","volume":"254","author":[{"given":"Stefano","family":"Barco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Abele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederikus A.","family":"Klok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Trinchero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Malcovati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros V.","family":"Konstantinides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109452_bb0005","unstructured":"Medical Expenditure Panel Survey (MEPS) 2013-2022. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. https:\/\/www.ahrq.gov\/data\/meps.html."},{"issue":"5","key":"10.1016\/j.thromres.2025.109452_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-098129","article-title":"Temporal trends and patient determinants of geographical variation in oral anticoagulant treatment of atrial fibrillation: a Danish nationwide cohort study in 2013-2022","volume":"15","author":"Laugesen","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.thromres.2025.109452_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fct.2018.01.019","article-title":"Effects of warfarin on biological processes other than haemostasis: a review","volume":"113","author":"Popov Aleksandrov","year":"2018","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109452_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/jamainternmed.2019.5679","article-title":"Association of anticoagulant therapy with risk of fracture among patients with atrial fibrillation","volume":"180","author":"Lutsey","year":"2020","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109452_bb0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/bcpt.12834","article-title":"Vascular calcification, vitamin K and warfarin therapy - possible or plausible connection?","volume":"122","author":"Siltari","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109452_bb0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood.2018874214","article-title":"Vitamin K antagonism impairs the bone marrow microenvironment and hematopoiesis","volume":"134","author":"Verma","year":"2019","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.thromres.2025.109452_bb0035","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.thromres.2025.109452_bb0040","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"Hokusai","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.thromres.2025.109452_bb0045","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/01.CIR.0000063575.17904.4E","article-title":"American Heart Association\/American College of Cardiology Foundation Guide to Warfarin Therapy","volume":"107","author":"Hirsh","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2025.109452_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12959-019-0194-8","article-title":"Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases","volume":"17","author":"Heuberger","year":"2019","journal-title":"Thromb. J."},{"issue":"5","key":"10.1016\/j.thromres.2025.109452_bb0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nri2303","article-title":"Immunobiology of the TAM receptors","volume":"8","author":"Lemke","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.thromres.2025.109452_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107403","article-title":"Protein Z and Protein Z-dependent protease inhibitor in patients with acute ischemic stroke: a prospective mechanistic study","volume":"32","author":"Pan","year":"2023","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.thromres.2025.109452_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13500","article-title":"Outside-in integrin signalling regulates haematopoietic stem cell function via Periostin-Itgav axis","volume":"7","author":"Khurana","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.thromres.2025.109452_bb0070","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.bbrc.2016.09.008","article-title":"Periostin supports hematopoietic progenitor cells and niche-dependent myeloblastoma cells in vitro","volume":"478","author":"Tanaka","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.thromres.2025.109452_bb0075","article-title":"Relationship between indices of circulating blood cells and bone homeostasis in osteoporosis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.thromres.2025.109452_bb0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archinte.166.2.241","article-title":"Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2","volume":"166","author":"Gage","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.thromres.2025.109452_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013845","article-title":"Risk of osteoporosis in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants or warfarin","volume":"9","author":"Huang","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.thromres.2025.109452_bb0090","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1016\/j.thromres.2013.02.012","article-title":"Immunomodulatory effects in vitro of vitamin K antagonist acenocoumarol","volume":"131","author":"Schroecksnadel","year":"2013","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2025.109452_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28052075","article-title":"Acenocoumarol exerts anti-inflammatory activity via the suppression of NF-kappaB and MAPK pathways in RAW 264.7 cells","volume":"28","author":"Han","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.thromres.2025.109452_bb0100","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.imbio.2009.08.007","article-title":"Interferon-gamma-mediated pathways are induced in human CD34(+) haematopoietic stem cells","volume":"215","author":"Kurz","year":"2010","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.thromres.2025.109452_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/1547691X.2012.684159","article-title":"Oral warfarin affects peripheral blood leukocyte IL-6 and TNFalpha production in rats","volume":"10","author":"Popov","year":"2013","journal-title":"J. Immunotoxicol."},{"issue":"6","key":"10.1016\/j.thromres.2025.109452_bb0110","first-page":"1396","article-title":"Dichotomal effect of the coumadin derivative warfarin on inflammatory signal transduction","volume":"9","author":"Kater","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109452_bb0115","first-page":"E1","article-title":"Low-dose warfarin functions as an immunomodulator to prevent cyclophosphamide-induced NOD diabetes","volume":"54","author":"Kurohara","year":"2008","journal-title":"Kobe J. Med. Sci."},{"key":"10.1016\/j.thromres.2025.109452_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1509228","article-title":"Vitamin K supports TGF-beta1 depended in vitro human Langerhans cell differentiation and function via Axl","volume":"16","author":"Bauer","year":"2025","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.thromres.2025.109452_bb0125","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1182\/blood-2016-06-724351","article-title":"Complex formation with pentraxin-2 regulates factor X plasma levels and macrophage interactions","volume":"129","author":"Muczynski","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2025.109452_bb0130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1756-185X.2009.01395.x","article-title":"Reduced bone density in patients on long-term warfarin","volume":"12","author":"Rezaieyazdi","year":"2009","journal-title":"Int. J. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.thromres.2025.109452_bb0135","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0034-1543999","article-title":"Oral anticoagulant drugs and the risk of osteoporosis: new anticoagulants better than old?","volume":"41","author":"Tufano","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"issue":"26","key":"10.1016\/j.thromres.2025.109452_bb0140","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2025.109452_bb0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1055\/s-0039-1678546","article-title":"Determinants of the quality of warfarin control after venous thromboembolism and validation of the SAMe-TT2-R2 score: an analysis of Hokusai-VTE","volume":"119","author":"Barco","year":"2019","journal-title":"Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:40:11Z","timestamp":1762249211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825002026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":29,"alternative-id":["S0049384825002026"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109452","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Warfarin reduces circulating white blood cell count: Post-hoc analysis of two randomized trials","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109452"}}